The mechanism of CIITA induction in melanoma is unknown, but MHC class II expression parallels the expression of chemokines CXCL-1 and CXCL-8 and the nuclear expression of NFκB p50 subunit, which are associated with tumor invasiveness and poor prognosis in melanoma (63). The gene discussed is NFKB1; the disease is melanoma.